thyroid cancer
New Cancer Susceptibility Genes Identified in Germline Genetic Variation Study
Researchers tracked down six genes with ties to increased or decreased cancer risk in a study involving nearly 864,500 European ancestry individuals with or without cancer.
UBS Initiates Coverage of Veracyte With Buy Rating
Analysts noted that they envision "durable growth" in Veracyte's Afirma and Decipher Prostate tests and "long-term growth potential" from its MRD testing business.
Veracyte Q2 Revenues up 27 Percent on Prostate, Thyroid Tests; Firm Raises Full-Year Guidance
The company said that it set records for test volume for both its Decipher Prostate test and Afirma assay for thyroid nodule risk stratification.
Veracyte Core Tests Maintain Growth as Firm Prepares to Shift Resources to Newest Acquisitions
Premium
The company is anticipating that its new MRD platform, acquired earlier this year, will be fuel for significant future development and expansion.
Polygenic Risk Scores Help Inform Adult Cancer Risk in Childhood Cancer Survivors
Researchers found that cancer-specific PRS and individuals' history of high radiation treatment could help predict development of a handful of adult cancer types.